Phillips Andrew John

Director at ELVN

Sold, on record
None
Dollars the filings state
Form 4 sales
0
None on record
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ELVNEnliven Therapeutics, Inc.Director

Sales by reason

No Form 4 sale on record for Phillips Andrew John.

Timeline

  1. Mar 31, 2026Notice

    ELVN

    Filed a notice to sell 26,035 shares

    $1M26,035 shares

    Filed Mar 31, 2026Form 144

  2. Feb 2, 2026Notice

    ELVN

    Filed a notice to sell 21,844 shares

    $612k21,844 shares

    Filed Feb 2, 2026Form 144

2 of 2

Every transaction

Every transaction on a Form 4 or Form 5 by Phillips Andrew John
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Aug 7, 2026Aug 11, 2026OKURDirectorAwardedStock Option (right to buy)22,35022,350SEC
Jun 17, 2026Jun 18, 2026MLTXDirectorAwardedOption to Buy22,19522,195SEC
Jun 4, 2026Jun 8, 2026OKURDirectorAwardedStock Option (right to buy)7,6507,650SEC
Jun 5, 2025Jun 9, 2025MLTXDirectorAwardedOption to Buy6,6826,682SEC
May 28, 2025May 30, 2025OKURDirectorAwardedStock Option (right to buy)7,6507,650SEC
Feb 6, 2025Feb 10, 2025ELVNDirectorAwardedStock Option (right to buy)20,49120,491SEC
Oct 4, 2024Oct 8, 2024OKURDirectorAwardedStock Option (right to buy)15,30015,300SEC
Jun 6, 2024Jun 7, 2024MLTXDirectorAwardedOption to Buy7,6887,688SEC
Feb 13, 2024Feb 15, 2024ELVNDirectorAwardedStock Option (right to buy)16,83516,835SEC
Jun 8, 2023Jun 12, 2023MLTXDirectorAwardedOption to Buy11,29711,297SEC
Feb 23, 2023Apr 6, 2023ELVNDirectorAwardedStock Option (right to buy)27,56727,567SEC
Apr 6, 2022May 5, 2022MLTXDirectorAwardedOption to Buy45,00045,000SEC

Sales and notices (2)

Form 144 notices and Form 4 sales by Phillips Andrew John
Source
Mar 31, 2026Mar 31, 2026ELVNDirectorForm 144 notice26,035$1MNoticeSEC
Feb 2, 2026Feb 2, 2026ELVNDirectorForm 144 notice21,844$612kNoticeSEC